View in EDS

Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) standardized template for collection of key information for benefit-risk assessment of live-attenuated viral vaccines.

Saved in:
Bibliographic Details
Title: Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) standardized template for collection of key information for benefit-risk assessment of live-attenuated viral vaccines.
Authors: Gurwith M; Brighton Collaboration, A Program of the Task Force for Global Health, Decatur, GA, USA., Condit RC; Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, FL, USA., Excler JL; International Vaccine Institute, Seoul, Republic of Korea., Robertson JS; Independent Adviser, United Kingdom., Kim D; Janssen Pharmaceuticals, Titusville, NJ, USA., Fast PE; International AIDS Vaccine Initiative, New York, NY, USA; Stanford School of Medicine, Paolo Alto, CA, USA., Drew S; Independent Adviser, USA., Wood D; Independent Adviser, United Kingdom., Klug B; Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, Langen, Germany., Whelan M; Project Leader, CEPI, UK., Mallett Moore T; Sanofi Pasteur, Swiftwater, PA, USA., Khuri-Bulos N; University of Jordan, Amman, Jordan., Smith ER; Brighton Collaboration, A Program of the Task Force for Global Health, Decatur, GA, USA. Electronic address: bc-coordinator@taskforce.org., Chen RT; Brighton Collaboration, A Program of the Task Force for Global Health, Decatur, GA, USA., Kochhar S; Global Healthcare Consulting, New Delhi, India; University of Washington, Seattle, WA, USA.
Corporate Authors: Brighton Collaboration Viral Vector Vaccines Safety Working Group V3SWG
Source: Vaccine [Vaccine] 2020 Nov 17; Vol. 38 (49), pp. 7702-7707. Date of Electronic Publication: 2020 Oct 16.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33070999
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) standardized template for collection of key information for benefit-risk assessment of live-attenuated viral vaccines.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gurwith+M%22">Gurwith M</searchLink>; Brighton Collaboration, A Program of the Task Force for Global Health, Decatur, GA, USA.<br /><searchLink fieldCode="AU" term="%22Condit+RC%22">Condit RC</searchLink>; Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Excler+JL%22">Excler JL</searchLink>; International Vaccine Institute, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Robertson+JS%22">Robertson JS</searchLink>; Independent Adviser, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Kim+D%22">Kim D</searchLink>; Janssen Pharmaceuticals, Titusville, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Fast+PE%22">Fast PE</searchLink>; International AIDS Vaccine Initiative, New York, NY, USA; Stanford School of Medicine, Paolo Alto, CA, USA.<br /><searchLink fieldCode="AU" term="%22Drew+S%22">Drew S</searchLink>; Independent Adviser, USA.<br /><searchLink fieldCode="AU" term="%22Wood+D%22">Wood D</searchLink>; Independent Adviser, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Klug+B%22">Klug B</searchLink>; Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, Langen, Germany.<br /><searchLink fieldCode="AU" term="%22Whelan+M%22">Whelan M</searchLink>; Project Leader, CEPI, UK.<br /><searchLink fieldCode="AU" term="%22Mallett+Moore+T%22">Mallett Moore T</searchLink>; Sanofi Pasteur, Swiftwater, PA, USA.<br /><searchLink fieldCode="AU" term="%22Khuri-Bulos+N%22">Khuri-Bulos N</searchLink>; University of Jordan, Amman, Jordan.<br /><searchLink fieldCode="AU" term="%22Smith+ER%22">Smith ER</searchLink>; Brighton Collaboration, A Program of the Task Force for Global Health, Decatur, GA, USA. Electronic address: bc-coordinator@taskforce.org.<br /><searchLink fieldCode="AU" term="%22Chen+RT%22">Chen RT</searchLink>; Brighton Collaboration, A Program of the Task Force for Global Health, Decatur, GA, USA.<br /><searchLink fieldCode="AU" term="%22Kochhar+S%22">Kochhar S</searchLink>; Global Healthcare Consulting, New Delhi, India; University of Washington, Seattle, WA, USA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Brighton+Collaboration+Viral+Vector+Vaccines+Safety+Working+Group+V3SWG%22">Brighton Collaboration Viral Vector Vaccines Safety Working Group V3SWG</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228406899%22">Vaccine</searchLink> [Vaccine] 2020 Nov 17; Vol. 38 (49), pp. 7702-7707. <i>Date of Electronic Publication: </i>2020 Oct 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8406899 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-2518 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220264410X%22">0264410X </searchLink><i>NLM ISO Abbreviation: </i>Vaccine <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33070999
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.vaccine.2020.09.042
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 7702
    Titles:
      – TitleFull: Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) standardized template for collection of key information for benefit-risk assessment of live-attenuated viral vaccines.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gurwith M
      – PersonEntity:
          Name:
            NameFull: Condit RC
      – PersonEntity:
          Name:
            NameFull: Excler JL
      – PersonEntity:
          Name:
            NameFull: Robertson JS
      – PersonEntity:
          Name:
            NameFull: Kim D
      – PersonEntity:
          Name:
            NameFull: Fast PE
      – PersonEntity:
          Name:
            NameFull: Drew S
      – PersonEntity:
          Name:
            NameFull: Wood D
      – PersonEntity:
          Name:
            NameFull: Klug B
      – PersonEntity:
          Name:
            NameFull: Whelan M
      – PersonEntity:
          Name:
            NameFull: Mallett Moore T
      – PersonEntity:
          Name:
            NameFull: Khuri-Bulos N
      – PersonEntity:
          Name:
            NameFull: Smith ER
      – PersonEntity:
          Name:
            NameFull: Chen RT
      – PersonEntity:
          Name:
            NameFull: Kochhar S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 17
              M: 11
              Text: 2020 Nov 17
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1873-2518
          Numbering:
            – Type: volume
              Value: 38
            – Type: issue
              Value: 49
          Titles:
            – TitleFull: Vaccine
              Type: main
ResultId 1